LBIC acquires MILabs' new diagnostic X-Ray CT system to extend its preclinical imaging capabilities

LBIC acquires MILabs' new diagnostic X-Ray CT system to extend its preclinical imaging capabilities

The Bioimaging Center of Lund University is a leading trans-faculty research center that houses a wide range of advanced preclinical and clinical imaging equipment. To further extend its preclinical imaging capabilities, LBIC recently acquired a MILabs uCT diagnostic X-ray CT system. This system has the unique ability to rapidly acquire dynamic 4D CT images at very-low radiation doses and with ultra-high-resolution. Moreover, because of its high resolution, the system is also suited for detailed 3D ex-vivo imaging studies. According to Dr. Marie Sydoff; responsible physicist at the Nuclear Medicine/CT platform at LBIC: Purchasing the MILabs micro-CT has redefined our research opportunities. The higher resolution, dual energy feature, as well as the overall better performance of the uCT gives us the opportunity to perform research projects in a much wider range than before. The improved image quality at low radiation dose makes it a great investment for our research environment.” Prod. F. Beekman, founder and CEO of MILabs adds: We are grateful that the LBIC has chosen our new diagnostic U-CT system. With its on-the-fly scanning capabilities and advanced multi-energy detector design, we believe that the system can currently deliver 3D and 4D CT images of unrivaled quality” Source:



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More